About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 296 record(s)
Req # A-2020-18434
Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18435
All briefing notes, memos, PowerPoints, policy briefs and reports submitted to the ISED Minister from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18442
A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18732
A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A 2020_0002
Hand written notes, emails and minutes of the June 2019 CDEV Board meeting approving $12.6 billion construction costs for the Trans Mountain expansion referred to in Q3 2019 Interim Report.Organization: Canada Development Investment Corporation
November 2020
Nothing to report this month
Organization: Canada Development Investment Corporation
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A 2019_0006
Copies of written reports and financial information sent to the head of CDEV and/or to the Minister of Finance between Jan. 1, 2019 and Sept. 11, 2019, related to Canada TMP Finance Limited and/or Trans Mountain Corporation. Please exclude likely cabinet confidences. Exclude HR policies, board controls and reports that have already been made public.Organization: Canada Development Investment Corporation
October 2020
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A 2020_0005
A copy of the Memorandum of Understanding between CDEV and the Department of Natural Resources Canada regarding the Net Profit Interest and Incidental Net Profits Interest (NPI) related to the Hibernia oil project.Organization: Canada Development Investment Corporation
September 2020